About Celares
Celares is a Healthcare company based in Berlin (Germany) founded in 2003 by Ralf Kraehmer, Frank Leenders, and Guenther Paetz, and was acquired by Biosynth in July 2023. Drug delivery systems using PEGylation for biopharmaceuticals are developed. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified.
Company details
Celares was founded in 2003 in Berlin, Germany, within the biopharmaceutical sector. PEGylation technologies are focused on for enhancing peptide and protein drugs through prolonged half-life, reduced immunogenicity, and improved stability. Patent applications are held for branched, monodispersed PEG reagents. Contract development services and customized reagent synthesis are also provided to support biopharmaceutical operations.
- Headquarters Berlin, Germany
- Founders Ralf Kraehmer, Frank Leenders, Guenther Paetz
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website celares.com
- Acquired by Biosynth (Jul 2023)
Investors in Celares
Celares has secured backing from 1 investor. Prominent investors backing the company include Biosynth.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biosynth is engaged in supplying critical raw materials and services for life sciences and diagnostics. | 1966 | biosynth.com | Thal, Switzerland |
Investor details for Celares
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Celares
3 people are tracked at Celares (3 in leadership).
| Name | Role | Group |
|---|---|---|
Ralf Kraehmer | Co-Founder & CSO | Leadership |
Frank Leenders | Co-Founder & Managing Director | Leadership |
Guenther Paetz | Co-Founder | Leadership |
Complete people profiles for Celares
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Celares
2 dated milestones of Celares across 20 years, from founding to its latest funding, stage changes and deals.
- Founded Celares is founded.
- Exit Acquired by Biosynth.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Celares
Complete news archive for Celares
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Celares
Celares was founded in 2003.
Celares is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
Celares was founded in 2003 in Berlin, Germany, within the biopharmaceutical sector. PEGylation technologies are focused on for enhancing peptide and protein drugs through prolonged half-life, reduced immunogenicity, and improved stability. Patent applications are held for branched, monodispersed PEG reagents. Contract development services and customized reagent synthesis are also provided to support biopharmaceutical operations.
Celares has 1 investor. Key investors include Biosynth.
Yes. Celares was acquired by Biosynth in July 2023.